Deep intronic founder mutations identified in the ERCC4/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum

Just a moment…

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : National Academy of Sciences – https://www.pnas.org/doi/abs/10.1073/pnas.2217423120?af=R

Exit mobile version